M&A Deal Summary |
|
|---|---|
| Date | 2020-09-03 |
| Target | Deep Longevity |
| Sector | Information Technology |
| Buyer(s) | Regent Pacific Group |
| Deal Type | Add-on Acquisition |
| Deal Value | 4M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1991 |
| Sector | Financial Services |
| Employees | 17 |
| Revenue | 3M HKD (2021) |
Regent Pacific Group is a diversified investment group currently holding various corporate and strategic investments focusing on the healthcare and life sciences sectors. The company engages in the research, development, manufacture, marketing, and sale of pharmaceutical products. Regent Pacific Group was founded in 1991 and is based in Hong Kong, China.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (Information Technology) | 1 of 1 |
| Type (Add-on Acquisition) | 2 of 2 |
| Country (China) | 1 of 1 |
| Year (2020) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-10 |
Plethora Solutions Holdings
London, United Kingdom Plethora Solutions Holdings PLC is a specialist pharmaceutical business focused on developing products for the treatment and management of urological disorders. Plethora was founded in 2003, before being listed on AIM in 2005. The company has grown in response to increasing demand for its products which serve a large, growing patient population whose medical needs are currently poorly met. Plethora has grown from a cash consumptive development company into a sustainable urology business benefiting from both near term product sales and high value, medium term licensing income. |
Buy | - |
